Our team specializes in oral solid dosage (OSD) formulation development and phase I/II and early Phase III clinical supply manufacturing for trials worldwide.
We are specialists, so what we do, we do very well!
Browse our site to learn more about how we use our unique skill-set and specialized equipment to unlock the full potential of your drug product.
Corealis offers specialized expertise in solid dose clinical formulation development, with extended proficiency in clinical supply manufacturing. The company’s advanced facilities can manage the most challenging formulation and manufacturing projects.
Corealis’ team develops high-quality, phase-appropriate drug products to meet exacting client and regulatory standards. The company achieves its primary aim of exceeding client expectations through prioritizing timely delivery, and executing on precise specifications.
Corealis is an accomplished formulation development service provider and a turnkey project specialist — managing and simplifying the development and manufacturing process of clients’ drug products.
Corealis is committed to the timely completion of project deliverables, ensuring client confidence. And are always ready to step in with a helping hand at any phase of the development process.
Corealis exhausts every option to ensure success. The team are renowned for giving promising APIs new life and rescuing challenging projects.
As part of the company’s working contract with clients, stringent adherence to regulatory guidelines and robust scientific expertise assure that the drug formulation progresses smoothly through all phases of clinical development.
This is achieved by:
Commitment to excellence sets Corealis apart, with an approach to development and cGMP manufacturing that stands out throughout the product journey. Corealis prides itself on being a reliable partner and is dedicated to meeting customer needs — every step of the way.
Corealis’ experts are ready to answer any queries about the company’s oral solid dose offering, including its development and manufacturing capabilities.
